AUSTRALASIAN COLLEGE OF PHLEBOLOGY ABSTRACT DEADLINE JAN. 7; KEYNOTERS NAMED
300-word abstracts for the 20th Annual Scientific Meeting of the Australasian College of Phlebology in Cairns, Queensland from May 5-7, 2019 are being accepted for either an oral presentation or poster presentation until Jan. 7, 2019, and notification of accepted abstracts will be made by Jan. 21.
Research abstracts must include an introduction, methods, results and a conclusion. Case presentations must include methods, results and a conclusion. For more information about submitting an abstract, see phlebology.com.au/acp2019/Abstracts?mc_cid=71e481fcb0&mc_eid=4db5a9f916
Registration is now open, but early-bird registration closes Feb. 4, 2019.
The Annual Scientific Meeting will include keynote speakers, presentations of original papers, panel discussions and the annual keepad interactive debates. The Phlebology Refresher Course will be offered before the annual meeting on Saturday, May 4.
Program themes include: Anatomy; basic science research; case presentations; chronic cerebrospinal venous insufficiency; complex disease compression; cosmetic phlebology and cosmetic medicine; deep vein reconstruction; deep venous disease; dermatological; manifestations of venous disease; fluid mechanics; glue ablation; gonadal, pelvic and vulvar veins; interventional radiology; lymphatic disease and lymphoedema; microcirculation; nursing in phlebology; edema; post-thrombotic syndrome; sclerotherapy; ulcers and wound care; ultrasound; vascular anomalies; venous interventions and surgery; venous hemodynamics; and venous thromboembolism.
Show presenters have announced two keynoters to date: Johann Christof Ragg, MD, of Germany, and Lowell Kabnick, MD, of the United States.
A German vein specialist and researcher, Dr. Ragg is a phlebologist who founded the Angioclinic Vein Centers in 2003 in Berlin. He also has a degree in laser physics.
For many years, Dr. Ragg has conducted research in vascular medicine and holds many patents. He has published multiple articles on the use of hyaluronan in venous procedures and on film compression bandages.
He has won multiple awards for research presentations from the American College of Phlebology, European Venous Forum, American Venous Forum, the German Society of Phlebology and the International Union of Phlebology.
Also delivering a keynote address will be Vein Therapy News Editorial Advisory Board member Dr. Kabnick, who is president of the American Venous Forum Foundation and vice president of the International Union of Phlebology. He is the former director of the New York University Vein Center.
Dr. Kabnick is a world-renowned surgeon-teacher who provides a patient-centered approach to vein care, enabling the creation and improvement of many of today’s most advanced non-invasive vascular surgery techniques.
He is recognized by his peers as an international authority on the diagnosis and treatment of venous disease. Highly sought after as a consultant and teacher by medical societies the world over, he has consistently been recognized as one of the area’s “Top Doctors” and is listed in the Guide to “America’s Top Surgeons.” He limits his practice exclusively to venous diagnosis and treatment.
Dr. Kabnick is board certified in surgery as well as phlebology and is a registered phlebology sonographer.
He is a Fellow of the American College of Surgeons as well as the American College of Phlebology. He presently sits on the Board of Directors for the American College of Phlebology in addition to the Board of Directors for the Intersocietal Accreditation Commission (IAC) for Vein Centers.
Dr. Kabnick was the first vascular surgeon in the United States to perform the VNUS Closure and the VenaCure EVLT (endovenous laser) procedure—two breakthrough technologies for treating the underlying causes of many varicose vein problems. VTN
READ MORE: phlebology.com.au/acp2019